GGrantIndex
← Search

PHASE I: RT + PACLITAXEL PLUS DOSE ESCALATION OF CARBOPLATIN IN CERVICAL CANCER

$9,071M01FY2005RRNIH

New York University School Of Medicine, New York NY

Investigators

Linked publications & trials

View original record on NIH RePORTER →